Healthequity Inc
F:2HE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healthequity Inc
F:2HE
|
US |
|
K
|
KLA Corp
XMUN:KLA
|
US |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
|
Equinor ASA
F:DNQ
|
NO |
Wall St Price Targets
2HE Price Targets Summary
Healthequity Inc
According to Wall Street analysts, the average 1-year price target for 2HE is 117.35 EUR with a low forecast of 89.06 EUR and a high forecast of 137.81 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2HE's stock price target?
Price Target
117.35
EUR
According to Wall Street analysts, the average 1-year price target for 2HE is 117.35 EUR with a low forecast of 89.06 EUR and a high forecast of 137.81 EUR.
What is the Revenue forecast for Healthequity Inc?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Healthequity Inc?
Projected CAGR
28%
Over the last 12 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Healthequity Inc?
Projected CAGR
34%
The compound annual growth rate for Net Income over the next 3 years is 34%.
